方正證券11.4億元人幣轉讓股權 瑞信證券(中國)成爲全外資控制券商
方正證券擬以11.4億元人民幣向瑞信轉讓所持有的瑞信證券(中國)的49%股權,股權轉讓完成後瑞信證券(中國)將成爲繼摩通(JPM.US)及高盛(GS.US)後第3間由外資完全控制的券商。
瑞信證券(中國)爲方正證券與瑞信於2008年成立,成立初期方正證券持股比例爲66.7%,瑞信爲33.3%。2020年6月,瑞信以非公開協議方式單方面向瑞信證券增資後,瑞信持股比例增至51%。
瑞信證券(中國)上半年收入爲1.32億元,虧損1.05億元。截至6月底至公司資產總額爲16.4億元,淨資產爲14.1億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.